Rapid antimicrobial susceptibility testing for bacterial infections.
| Date | Round | Amount |
|---|---|---|
| Nov 2024 | Funding round iFAST raised an oversubscribed USD 6.5M round led by NHS-backed KHP Ventures to bring its rapid antibiotic-susceptibility test to market. | $6.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.